Printer-friendly versionPrinter-friendly version

Burden and Prevention of Viral Hepatitis in Bulgaria

Sofia, Bulgaria, March 24-25, 2011

Thursday, March 24, 2011

Session 1  Opening and objectives
Chair:  Angel Kunchev, Mira Kojouharova

09.00 - 09.30

  • Welcome and opening
  • Introduction of the participants
  • Introduction of the VHPB:     1.4 Mb(.pdf)  by  Pierre Van Damme
  • Objectives of the meeting:
    • Provide an overview of surveillance systems for infectious diseases;
    • Review the epidemiological situation on viral hepatitis;
    • Give an overview of the current prevention and control measures on viral hepatitis;
    • Discuss the progress achieved in hepatitis prevention 20 years after the introduction of Universal Hepatitis B vaccination;
    • Review the possible implementation of new prevention strategies, control measures and monitoring systems;
    • Discuss the successes, problems and barriers to overcome, and the way forward
  • Review of the meeting programme
  • Pre-meeting document   KB (.pdf)

09.30 – 10.00
Impact of the hepatitis resolution adopted by the World Health Assembly (WHA 63.18)  236 Kb (.pdf)
Steven Wiersma

Session 2 The Health Care system in Bulgaria
Chair:  Angela Dominguez , Nadezhda Vladimirova

10.30 – 10.50
Organisation and funding of the health system in Bulgaria  1.6 Mb (.pdf)
Tatiana Ivanova

10.50 – 11.10
National immunisation program    657Kb (.pdf)
Radosveta Filipova

11.10 – 11.30
Overview of communicable disease surveillance system in Bulgaria   872Kb (.pdf)
Mira Kojouharova

11.30 – 11.45
Healthcare Policy for vulnerable groups, especially Roma in Bulgaria  783 Kb (.pdf)
Rossitsa Ivanova

11.45 – 12.00
Concept of health mediators – history, job description and mediator’s activities 2.4 Mb (.pdf)
Ivailo Tarnev

12.00 – 12.20 Discussion

12.20 – 13.40 Lunch

Session 3 Epidemiology of viral hepatitis in Bulgaria
Chair: Wolfgang Jilg , Nina Gatcheva

13.40 – 14.00
Epidemiology of viral hepatitis in Bulgaria.  519 Kb (.pdf)
Nadezhda Vladimirova,

14.00 – 14.20
Molecular epidemiology of HBV and HCV.  1.9 Mb (.pdf)
Pavel Teoharov

14.20 – 14.40
Phylogenetic reconstruction of two large HAV outbreaks occurring simultaneously in different regions in Bulgaria   1.7 Mb (.pdf)
Anton Andonov  

14.40 – 15.00
Seroepidemiological study on HBV and HCV prevalence in Bulgaria   1.7 Mb (.pdf)
Ani Kevorkian  

15.00 – 15.20
Viral hepatitis and surveillance in Blood bank in Bulgaria.    1.5 Mb (.pdf)
Svetla Bakalova  

15.20 – 15.30 Discussion

15.30 – 15.50 Lunch

Chair: Daniel Shouval , Tatiana Tcherveniakova

15.50 – 16.10
IDU risk group and viral hepatitis    2.8 Mb (.pdf)
Violeta Bogdanova

16.10– 16.30
Sero-epidemiology of viral hepatitis in haemodialysis and control measures    461 Kb (.pdf)
Evgueniy Vazelov, V. Mushekov

16.30– 16.50
Health care-associated viral hepatitis C.   1 Mb (.pdf)
Rossitza Vatcheva-Dobrevska

16.50– 17.10
Quality of life of patients with HBV infection – case study with SF-36.   453 Kb (.pdf)
Alexandra Tzenova-Savova

17.10– 17.30
Viral hepatitis- The patients’ impact in Bulgaria. (Hepasist).   1.2 Mb (.pdf)
Stanimir Hasurdjiev

17.30 – 17.45   Discussion

17.45 – 15.05    End of the Day

 

Friday, March 25, 2011

Session 4  Prevention and Control of viral hepatitis in Bulgaria
Chair: Mark Kane ,  Anton Andonov

09.00 – 09.20
Clinical aspects of viral hepatitis.3.9 Mb (.pdf)
Tatiana Tcherveniakova

09.20 – 09.40
Treatment and laboratory monitoring of chronic hepatitis patients in Bulgaria.  1.8 MB (pdf)
Krassimir Antonov

09.40 – 10.00
Control of viral hepatitis in haemodialysis. 
Stefan Krivoshiev

10.00 – 10.20
Hepatitis A in city of Plovdiv in 2006 – outbreak investigation and control measures     1.9 Mb (.pdf)
Angel Kunchev, Monika Troyancheva

10.20 – 10.30 Discussion

10.30 – 10.50 Coffee break

Session 5  Evaluation of the Prevention and Control of Viral Hepatitis in Bulgaria
Chair:Liudmilla Mosina , Krassimir Antonov

10.50 – 11.10
National Hepatitis B vaccination programme: cost-benefit assessment of introduction of universal HBV vaccination of newborns in Bulgaria   454Kb (.pdf)
Anna Kurchatova

11.10 – 11.30
Epidemiological effectiveness of the universal newborn HBV vaccination: 20 years after.    89 Kb (.pdf)
Mira Kojouharova 

11.30 – 11.50
Economic analysis of the universal HBV vaccination 20 years after introduction.    826 Kb (.pdf)
Guenka Petrova

11.50 – 12.10
Protection of medical staff through hepatitis B vaccination: serological and epidemiological data from hospitals in Bulgaria    1.4 Mb (.pdf)
Nina Gatcheva

12.10 – 12.30
Our experience in prevention by selective immunization against viral hepatitis A and B of the staff of Military Medical Academy – Bulgaria   1.8 Mb (.pdf)
Andrey Galev

12.30 – 12.45 Discussion

12.45 – 14.10 Lunch

Session 6 Conclusions of the meeting
Chair: Johannes Hallauer , Mira Kojouharova

14.15 – 15.15
Presentation of the VHPB meeting conclusions   64 Kb(.pdf)
David FitzSimons

15.15 Close of the meeting

Tags: